Wire Stories
Prestige BioPharma and Dr. Reddy�s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia
SINGAPORE–(BUSINESS WIRE)–Prestige BioPharma Ltd. (KRX: 950210) and Dr. Reddy�s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred to...